AnalystBook Research · Company Intelligence

FORMFACTOR INC

FORMNasdaq

Built from FORMFACTOR INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Revenue increased 2.8% to $785.0M, while Net income decreased 21.9% to $54.4M.

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue $785.0MOK
  • ProfitabilityNet income $54.4MOK
  • Cash generationFree cash flow $11.7MOK
  • AccountingDistress-safe · no manipulation flag · earnings quality safeOK
  • Insiders0 buys; 26 sells in 365 daysNote
  • Capitalshare repurchases were $26.2MNote

Business

FORMFACTOR INC: As of December 27, 2025, we operate in two reportable segments consisting of the Probe Cards segment and the Systems segment.

Where the revenue comes from

Fiscal 2025, as FORMFACTOR INC reports it. History and quarterly detail are in the app.

  • Probe Cards$637.9M
  • Systems$147.1M

Leadership changes

From FORMFACTOR INC's own filings, the day they're filed.

  • Kevin Brewer · director · departureeff. 2026-02-13
  • Aric McKinnis · President · appointmenteff. 2025-08-08
  • Kevin Brewer · director · appointmenteff. 2024-03-19

Latest filings

  • 10-Q · Quarterly report2026-08-04
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-05-19
  • 10-Q · Quarterly report2026-05-05
  • 8-K · Company announcement2026-04-29
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about FORMFACTOR INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.